A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2001
10/17/2001	EP1144652A1 Manipulating isoprenoid expression
10/17/2001	EP1144648A1 Cyclic nucleotide-associated proteins
10/17/2001	EP1144645A1 Neisseria meningitidis polypeptide basb052
10/17/2001	EP1144644A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
10/17/2001	EP1144640A2 Nucleic acids and proteins from streptococcus pneumoniae
10/17/2001	EP1144639A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection
10/17/2001	EP1144634A2 Novel complex-forming proteins
10/17/2001	EP1144623A1 Method and medicament for inhibiting the expression of a defined gene
10/17/2001	EP1144621A2 Genetic suppressor elements against human immunodeficiency virus
10/17/2001	EP1144618A1 Method for isolating apoptosis-inducing dna sequences and detection system
10/17/2001	EP1144614A2 33 human secreted proteins
10/17/2001	EP1144605A2 Dimethylarginine dimethylaminohydrolases
10/17/2001	EP1144598A2 Human homologues of proteins regulated by circadian rhythms
10/17/2001	EP1144454A2 Modified peptides as therapeutic agents
10/17/2001	EP1144446A1 Pharmaceutical compounds for the inhibition of hepatitis c virus ns3 protease
10/17/2001	EP1144443A2 Human membrane transport proteins
10/17/2001	EP1144442A2 Streptococcal alpha2m-binding protein
10/17/2001	EP1144432A1 Steroid derived antibiotics
10/17/2001	EP1144428A1 Method for preparing an aza-macrolide with 4"(r)-nh2
10/17/2001	EP1144420A1 Sulfated phosphatidylinositols, their preparation and use
10/17/2001	EP1144418A1 3,6-disubstituted penam sulfone derivatives as antibacterials
10/17/2001	EP1144415A2 Functionalized heterocycles as chemokine receptor modulators
10/17/2001	EP1144414A2 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
10/17/2001	EP1144406A1 Antifungal azole derivatives having a fluorinated vinyl group and process for preparing same
10/17/2001	EP1144404A1 Piperidinylquinolines as protein tyrosine kinase inhibitors
10/17/2001	EP1144399A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
10/17/2001	EP1144397A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
10/17/2001	EP1144394A1 1-heterocycle substituted diarylamines
10/17/2001	EP1144390A2 Kinase inhibitors
10/17/2001	EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001	EP1144385A1 Benzoheterocycles and their use as mek inhibitors
10/17/2001	EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001	EP1144372A1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
10/17/2001	EP1144371A1 Benzenesulphonamide derivatives and their use as mek inhibitors
10/17/2001	EP1144369A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/17/2001	EP1144368A2 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
10/17/2001	EP1144362A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
10/17/2001	EP1144313A1 Method for activating water and use of activated water of this type
10/17/2001	EP1144305A1 NOVEL sPLA 2 INHIBITORS
10/17/2001	EP1144008A1 Modulation of systemic memory t cell trafficking
10/17/2001	EP1144006A2 Synergistic inhibition of hiv-1 fusion and attachment, compositions and antibodies thereto
10/17/2001	EP1144005A1 Treatment of papillomavirus infections
10/17/2001	EP1144001A2 Inactivated influenza virus vaccine for nasal or oral administration
10/17/2001	EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001	EP1143990A2 Pharmaceutical compostions comprising peg-asparaginase for the treatment of hiv infections
10/17/2001	EP1143986A2 Plant-derived anti-parasitic and antifungal compounds and methods of extracting the compounds
10/17/2001	EP1143985A2 Use of lactobacillus salivarius
10/17/2001	EP1143981A1 Treatment and prevention of hiv and other viral infections
10/17/2001	EP1143976A2 Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine for use in the treatment of hiv infections
10/17/2001	EP1143966A1 Preparation for warts
10/17/2001	EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001	EP1143964A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
10/17/2001	EP1143960A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
10/17/2001	EP1143959A2 Antifungal activity of dicationic molecules
10/17/2001	EP1143950A2 Topical application products
10/17/2001	EP1143946A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
10/17/2001	EP1143944A2 Use of arylalkanoylpyridazines
10/17/2001	EP1143941A2 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
10/17/2001	EP1143940A2 Compositions and methods for mucosal delivery
10/17/2001	EP1143933A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
10/17/2001	EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers
10/17/2001	EP1143925A1 Topical composition comprising n-acetylaldosamines or n-acetylamino acids
10/17/2001	EP1143920A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system
10/17/2001	EP1143805A2 Methods for reducing mortality rates in poultry
10/17/2001	EP1113817A4 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
10/17/2001	EP0633784B2 Hepatitis vaccins containing 3-0 deacylated monophosphoryl lipid A
10/17/2001	CN1318103A Nucleic acids and proteins from streptococcus pneumoniae
10/17/2001	CN1318057A 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoliines as CETP inhibitors
10/17/2001	CN1317976A Multicomponent vaccines
10/17/2001	CN1317971A Antiviral combination comprising lamivudine and abacavir
10/17/2001	CN1317339A 'Leizhuqing' tincture
10/17/2001	CN1317338A Disinfectant for treating superficial vulve fungus infection and its preparing process
10/17/2001	CN1317330A Chinese medicine for treating cold and its preparing process
10/17/2001	CN1317317A 'Lifeiqing' capsule for treating pulmonary tuberculosis
10/17/2001	CN1317314A Kelamycin injection and its preparing process
10/17/2001	CN1073112C Possibly substituted 8-cyano-cyclopropyl-7-(2,8-diazabicyclo-[4,3,0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
10/17/2001	CN1072963C Vaccine compsns.
10/17/2001	CN1072961C Method of treating hepatitis C in non-responders to interferon treatment
10/16/2001	US6303774 Antiviral agents, anticancer agents, metabolic moderators
10/16/2001	US6303771 Pth
10/16/2001	US6303755 Therapeutic multispecific compounds comprised of anti-FCA receptor antibodies
10/16/2001	US6303637 For therapy of autoimmune disease, prophylaxis of resistance to transplantation or transplantation rejection of organs or tissues; suppressing immune system
10/16/2001	US6303636 Arylsulfonylamino hydroxamic acid derivatives
10/16/2001	US6303630 Diarylsulfone non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus
10/16/2001	US6303613 As nitric oxide synthase inhibitor useful in therapy or prophylaxis of inflammatory disease and pain
10/16/2001	US6303592 7-alkylidene cephalosporanic acid derivatives and methods of using the same
10/16/2001	US6303575 Indolicidin analogs and methods of using same
10/16/2001	US6303571 To screen for antibacterial compounds; genetic immunization; therapy and prophylaxis
10/16/2001	US6303376 Stimulation using cellular dna synthesis or repair mechanisms
10/16/2001	US6303334 Nucleotide sequences coding polypeptides for use in as a viricide and in gene therapy
10/16/2001	US6303321 Methods for diagnosing sepsis
10/16/2001	US6303292 Geneticlly engineered viral polypeptides; for use in diagnosis and treatment of viral infection
10/16/2001	US6303130 Pasteurella haemolytica vaccine inactivated by ultraviolet light
10/16/2001	US6303129 Production of borrelia burgdorferi vaccine, product produced thereby and method of use
10/16/2001	US6303128 Method for protein expression
10/16/2001	US6303125 Anti-microbial-adhesion fraction derived from vaccinium
10/16/2001	US6303118 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
10/16/2001	US6303115 Screening methods using microbial strain pools
10/16/2001	CA2241464C Nisin in combination with glycerol monolaurate active against helicobacter
10/16/2001	CA2089366C Penem compounds

1 ... 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 ... 1798